Autochthonous murine models for the study of smoker and neversmoker associated lung cancers

Research output: Contribution to journalReview article

Abstract

Lung cancer accounts for the greatest number of cancer deaths in the world. Tobacco smokeassociated cancers constitute the majority of lung cancer cases but never-smoker cancers comprise a significant and increasing fraction of cases. Recent genomic and transcriptomic sequencing efforts of lung cancers have revealed distinct sets of genetic aberrations of smoker and never-smoker lung cancers that implicate disparate biology and therapeutic strategies. Autochthonous mouse models have contributed greatly to our understanding of lung cancer biology and identified novel therapeutic targets and strategies in the era of targeted therapy. With the emergence of immuno-oncology, mouse models may continue to serve as valuable platforms for novel biological insights and therapeutic strategies. Here, we will review the variety of available autochthonous mouse models of lung cancer, their relation to human smoker and neversmoker lung cancers, and their application to immuno-oncology and immune checkpoint blockade that is revolutionizing lung cancer therapy.

Original languageEnglish (US)
Pages (from-to)464-486
Number of pages23
JournalTranslational Lung Cancer Research
Volume7
Issue number4
DOIs
StatePublished - Jan 1 2018

Fingerprint

Lung Neoplasms
Therapeutics
Neoplasms
Tobacco

Keywords

  • Lung cancer
  • Mouse models
  • Never-smoker
  • Smoker

ASJC Scopus subject areas

  • Oncology

Cite this

Autochthonous murine models for the study of smoker and neversmoker associated lung cancers. / Akbay, Esra A.; Kim, James.

In: Translational Lung Cancer Research, Vol. 7, No. 4, 01.01.2018, p. 464-486.

Research output: Contribution to journalReview article

@article{043ec2fbdf1e4264b83ffff7f3ca46b1,
title = "Autochthonous murine models for the study of smoker and neversmoker associated lung cancers",
abstract = "Lung cancer accounts for the greatest number of cancer deaths in the world. Tobacco smokeassociated cancers constitute the majority of lung cancer cases but never-smoker cancers comprise a significant and increasing fraction of cases. Recent genomic and transcriptomic sequencing efforts of lung cancers have revealed distinct sets of genetic aberrations of smoker and never-smoker lung cancers that implicate disparate biology and therapeutic strategies. Autochthonous mouse models have contributed greatly to our understanding of lung cancer biology and identified novel therapeutic targets and strategies in the era of targeted therapy. With the emergence of immuno-oncology, mouse models may continue to serve as valuable platforms for novel biological insights and therapeutic strategies. Here, we will review the variety of available autochthonous mouse models of lung cancer, their relation to human smoker and neversmoker lung cancers, and their application to immuno-oncology and immune checkpoint blockade that is revolutionizing lung cancer therapy.",
keywords = "Lung cancer, Mouse models, Never-smoker, Smoker",
author = "Akbay, {Esra A.} and James Kim",
year = "2018",
month = "1",
day = "1",
doi = "10.21037/tlcr.2018.06.04",
language = "English (US)",
volume = "7",
pages = "464--486",
journal = "Translational Lung Cancer Research",
issn = "2226-4477",
publisher = "Society for Translational Medicine (STM)",
number = "4",

}

TY - JOUR

T1 - Autochthonous murine models for the study of smoker and neversmoker associated lung cancers

AU - Akbay, Esra A.

AU - Kim, James

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Lung cancer accounts for the greatest number of cancer deaths in the world. Tobacco smokeassociated cancers constitute the majority of lung cancer cases but never-smoker cancers comprise a significant and increasing fraction of cases. Recent genomic and transcriptomic sequencing efforts of lung cancers have revealed distinct sets of genetic aberrations of smoker and never-smoker lung cancers that implicate disparate biology and therapeutic strategies. Autochthonous mouse models have contributed greatly to our understanding of lung cancer biology and identified novel therapeutic targets and strategies in the era of targeted therapy. With the emergence of immuno-oncology, mouse models may continue to serve as valuable platforms for novel biological insights and therapeutic strategies. Here, we will review the variety of available autochthonous mouse models of lung cancer, their relation to human smoker and neversmoker lung cancers, and their application to immuno-oncology and immune checkpoint blockade that is revolutionizing lung cancer therapy.

AB - Lung cancer accounts for the greatest number of cancer deaths in the world. Tobacco smokeassociated cancers constitute the majority of lung cancer cases but never-smoker cancers comprise a significant and increasing fraction of cases. Recent genomic and transcriptomic sequencing efforts of lung cancers have revealed distinct sets of genetic aberrations of smoker and never-smoker lung cancers that implicate disparate biology and therapeutic strategies. Autochthonous mouse models have contributed greatly to our understanding of lung cancer biology and identified novel therapeutic targets and strategies in the era of targeted therapy. With the emergence of immuno-oncology, mouse models may continue to serve as valuable platforms for novel biological insights and therapeutic strategies. Here, we will review the variety of available autochthonous mouse models of lung cancer, their relation to human smoker and neversmoker lung cancers, and their application to immuno-oncology and immune checkpoint blockade that is revolutionizing lung cancer therapy.

KW - Lung cancer

KW - Mouse models

KW - Never-smoker

KW - Smoker

UR - http://www.scopus.com/inward/record.url?scp=85052331710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052331710&partnerID=8YFLogxK

U2 - 10.21037/tlcr.2018.06.04

DO - 10.21037/tlcr.2018.06.04

M3 - Review article

C2 - 30225211

AN - SCOPUS:85052331710

VL - 7

SP - 464

EP - 486

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

SN - 2226-4477

IS - 4

ER -